Evidence map›Paper›PMID 37745323›Full record

ArticlebioRxiv : the preprint server for biology2023

Digitize your Biology! Modeling multicellular systems through interpretable cell behavior.

Jeanette A I Johnson, Genevieve L Stein-O'Brien, Max Booth, Randy Heiland, Furkan Kurtoglu, Daniel R Bergman, Elmar Bucher, Atul Deshpande, André Forjaz, Michael Getz and 25 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 14 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

35 authors at 6 institutions in 2 countries.

Jeanette A I JohnsonDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0002-8268-5335
Genevieve L Stein-O'BrienDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0001-8681-9110
Max BoothDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0009-0003-4707-5640
Randy HeilandDepartment of Intelligent Systems Engineering, Indiana University. Bloomington, IN USA.ORCID 0000-0002-7440-2905
Furkan KurtogluDepartment of Intelligent Systems Engineering, Indiana University. Bloomington, IN USA.ORCID 0000-0003-4547-1220
Daniel R BergmanDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0002-2166-6616
Elmar BucherDepartment of Intelligent Systems Engineering, Indiana University. Bloomington, IN USA.ORCID 0000-0002-2929-2460
Atul DeshpandeDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0001-5144-6924
André ForjazDepartment of Chemical and Biomolecular Engineering, Johns Hopkins University. Baltimore, MD USA.
Michael GetzDepartment of Intelligent Systems Engineering, Indiana University. Bloomington, IN USA.ORCID 0000-0001-9886-8454
Ines GodetMemorial Sloan Kettering Cancer Center. New York, NY USA.ORCID 0000-0002-4889-5144
Melissa LymanDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0002-0091-0413
John MetzcarDepartment of Intelligent Systems Engineering, Indiana University. Bloomington, IN USA.ORCID 0000-0002-0142-0387
Jacob MitchellConvergence Institute, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0002-5370-9692
Andrew RaddatzDepartment of Biomedical Engineering, Georgia Institute of Technology, Emory University. Atlanta, GA USA.ORCID 0000-0001-6096-0968
Heber RochaDepartment of Intelligent Systems Engineering, Indiana University. Bloomington, IN USA.ORCID 0000-0002-5876-2644
Jacobo SolorzanoCentre de Recherches en Cancerologie de Toulouse. Toulouse, France.ORCID 0000-0003-1199-2239
Aneequa SundusDepartment of Intelligent Systems Engineering, Indiana University. Bloomington, IN USA.ORCID 0000-0001-6833-2341
Yafei WangDepartment of Intelligent Systems Engineering, Indiana University. Bloomington, IN USA.ORCID 0000-0001-6594-0608
Danielle GilkesDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0003-3984-9338
Luciane T KagoharaDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0003-1706-0950
Ashley L KiemenDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.
Elizabeth D ThompsonDepartment of Pathology, Johns Hopkins University. Baltimore, MD USA.
Denis WirtzDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0001-6147-3045
Pei-Hsun WuConvergence Institute, Johns Hopkins University. Baltimore, MD USA.
Neeha ZaidiDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0002-0094-0049
Lei ZhengDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.
Jacquelyn W ZimmermanDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0002-7775-2943
Elizabeth M JaffeeDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0003-3841-6549
Young Hwan ChangDepartment of Biomedical Engineering, Oregon Health & Science University. Portland, OR USA.ORCID 0000-0001-8764-1959
Lisa M CoussensDepartment of Cell, Developmental and Cancer Biology, Oregon Health & Science University. Portland, OR USA.ORCID 0000-0003-2389-1865
Joe W GrayDepartment of Biomedical Engineering, Oregon Health & Science University. Portland, OR USA.ORCID 0000-0001-9225-6756
Laura M HeiserDepartment of Biomedical Engineering, Oregon Health & Science University. Portland, OR USA.ORCID 0000-0003-3330-0950
Elana J FertigDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University. Baltimore, MD USA.ORCID 0000-0003-3204-342X
Paul MacklinDepartment of Intelligent Systems Engineering, Indiana University. Bloomington, IN USA.ORCID 0000-0002-9925-0151
Johns Hopkins University · USIndiana University Bloomington · USOregon Health & Science University · USCentre de Recherche en Cancérologie de Toulouse · FRGeorgia Institute of Technology · USMemorial Sloan Kettering Cancer Center · US

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI ALAN KEITH MEEKER · 1985 to 2026
$208.6M
Tumor Antigens for Individual Signatures and TherapyP50CA062924 · NCI · JOHNS HOPKINS UNIVERSITY · PI THOMPSON, ELIZABETH D · 1993 to 2022
$54.6M
Transforming Human Pancreatic Cancer Into An Immunologic DiseaseP01CA247886 · NCI · JOHNS HOPKINS UNIVERSITY · PI AZAD, NILOFER S. · 2021 to 2025
$12.7M
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic CancerP50CA221707 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KOPETZ, SCOTT · 2019 to 2023
$11.0M
Tech Core 2U54CA268083 · NCI · JOHNS HOPKINS UNIVERSITY · PI Pei-Hsun wu · 2022 to 2026
$10.2M
Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic CancerU54CA274371 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Elana Fertig · 2022 to 2026
$9.5M
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical TrialR01CA197296 · NCI · JOHNS HOPKINS UNIVERSITY · PI William Reece Burns, Eric Christenson · 2015 to 2026
$5.7M
Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancerR01CA169702 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ZHENG, LEI · 2013 to 2023
$3.6M
T32: Predoctoral and Postdoctoral Training Program in Nanotechnology for Cancer ResearchT32CA153952 · NCI · JOHNS HOPKINS UNIVERSITY · PI Denis Wirtz · 2015 to 2026
$3.5M
Integrating bioinformatics into multiscale models for hepatocellular carcinomaU01CA212007 · NCI · JOHNS HOPKINS UNIVERSITY · PI EWALD, ANDREW JOSEF, FERTIG, ELANA · 2018 to 2022
$3.2M
Interrogation of the Impact of Selection on the Evolution of Human PancreaticCancer Precursor LesionsU01CA271273 · NCI · JOHNS HOPKINS UNIVERSITY · PI Elana Fertig, Rachel Karchin · 2022 to 2026
$2.8M
NCI NIH HHS 75N91019D00024NCI NIH HHS K08 CA248624NCI NIH HHS P01 CA247886NCI NIH HHS P30 CA006973NCI NIH HHS P50 CA062924NCI NIH HHS P50 CA221707NCI NIH HHS R01 CA169702NCI NIH HHS R01 CA197296NCI NIH HHS T32 CA153952NCI NIH HHS U01 CA212007NCI NIH HHS U01 CA232137NCI NIH HHS U01 CA253403NCI NIH HHS U01 CA271273NCI NIH HHS U24 CA284156NCI NIH HHS U54 CA268083NCI NIH HHS U54 CA274371NIGMS NIH HHS T32 GM148383NINDS NIH HHS K99 NS122085NINDS NIH HHS R00 NS122085
6 · The paper itself

Abstract

Cells are fundamental units of life, constantly interacting and evolving as dynamical systems. While recent spatial multi-omics can quantitate individual cells' characteristics and regulatory programs, forecasting their evolution ultimately requires mathematical modeling. We develop a conceptual framework-a cell behavior hypothesis grammar-that uses natural language statements (cell rules) to create mathematical models. This allows us to systematically integrate biological knowledge and multi-omics data to make them computable. We can then perform virtual "thought experiments" that challenge and extend our understanding of multicellular systems, and ultimately generate new testable hypotheses. In this paper, we motivate and describe the grammar, provide a reference implementation, and demonstrate its potential through a series of examples in tumor biology and immunotherapy. Altogether, this approach provides a bridge between biological, clinical, and systems biology researchers for mathematical modeling of biological systems at scale, allowing the community to extrapolate from single-cell characterization to emergent multicellular behavior.

Identifiers

PMID37745323
PMCPMC10516032
OpenAlexW4386811476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.